These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 38195532)
1. Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies. Fan Y; Wu M; Li X; Zhao J; Shi J; Ding L; Jiang H; Li Z; Zhang W; Ma T; Wang D; Ma L Nutr J; 2024 Jan; 23(1):8. PubMed ID: 38195532 [TBL] [Abstract][Full Text] [Related]
2. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies. Hoppe LK; Muhlack DC; Koenig W; Carr PR; Brenner H; Schöttker B Cardiovasc Drugs Ther; 2018 Apr; 32(2):197-212. PubMed ID: 29679302 [TBL] [Abstract][Full Text] [Related]
3. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Brand A; Visser ME; Schoonees A; Naude CE Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015207. PubMed ID: 35944931 [TBL] [Abstract][Full Text] [Related]
4. [Association between serum potassium levels and all-cause mortality in patients with acute heart failure]. Huang BP; Zhou Q; Zhao L; Zhao XM; Zhai M; Tian PC; Liang L; Huang LY; Feng JY; Zhang YH; Huang Y; Zhang J Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):727-732. PubMed ID: 36889685 [No Abstract] [Full Text] [Related]
5. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients. Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF; Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891 [TBL] [Abstract][Full Text] [Related]
6. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans. Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910 [TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of the severity of and prognosis associated with potassium abnormalities in dogs and cats presenting to an emergency room (January 2014-August 2015): 2441 cases. Hoehne SN; Hopper K; Epstein SE J Vet Emerg Crit Care (San Antonio); 2019 Nov; 29(6):653-661. PubMed ID: 31482659 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J Circulation; 2018 Mar; 137(13):1320-1330. PubMed ID: 29025765 [TBL] [Abstract][Full Text] [Related]
9. Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be? Tandukar S; Fried LF Nephron; 2018; 140(1):58-62. PubMed ID: 29972830 [TBL] [Abstract][Full Text] [Related]
10. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study. Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113 [TBL] [Abstract][Full Text] [Related]
11. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905 [TBL] [Abstract][Full Text] [Related]
12. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Mann JF; Yi QL; Sleight P; Dagenais GR; Gerstein HC; Lonn EM; Bosch J; Clin Nephrol; 2005 Mar; 63(3):181-7. PubMed ID: 15786818 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Alderman MH; Piller LB; Ford CE; Probstfield JL; Oparil S; Cushman WC; Einhorn PT; Franklin SS; Papademetriou V; Ong ST; Eckfeldt JH; Furberg CD; Calhoun DA; Davis BR; Hypertension; 2012 May; 59(5):926-33. PubMed ID: 22431578 [TBL] [Abstract][Full Text] [Related]
14. Serum potassium levels and mortality of patients with acute myocardial infarction: A systematic review and meta-analysis of cohort studies. Xi H; Yu RH; Wang N; Chen XZ; Zhang WC; Hong T Eur J Prev Cardiol; 2019 Jan; 26(2):145-156. PubMed ID: 31060369 [TBL] [Abstract][Full Text] [Related]
15. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702 [TBL] [Abstract][Full Text] [Related]
17. Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Hu H; Zhao Y; Feng Y; Yang X; Li Y; Wu Y; Yuan L; Zhang J; Li T; Huang H; Li X; Zhang M; Sun L; Hu D Am J Clin Nutr; 2023 Jan; 117(1):149-159. PubMed ID: 36789934 [TBL] [Abstract][Full Text] [Related]
18. Association of Serum Potassium Levels with Mortality and Cardiovascular Events: Findings from the Chinese Multi-provincial Cohort Study. Liu S; Zhao D; Wang M; Qi Y; Sun J; Liu J; Li Y; Liu J J Gen Intern Med; 2022 Aug; 37(10):2446-2453. PubMed ID: 34505984 [TBL] [Abstract][Full Text] [Related]
19. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD; Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304 [TBL] [Abstract][Full Text] [Related]